KIMBERLY VALDECANTOS: Open Payments
NPI 1851748339 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 15 payments from 6 companies in 2025. Trend: 2023 $201 · 2024 $808 · 2025 $579
Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $262 |
| Alnylam Pharmaceuticals Inc. | 4 | $129 |
| Kestra Medical Technology Services, Inc. | 2 | $59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $52 |
| Merck Sharp & Dohme LLC | 2 | $44 |
| PFIZER INC. | 2 | $33 |
Products named: CAMZYOS, AMVUTTRA, Assure WCD, JARDIANCE, VERQUVO, PREVNAR 20, VYNDAQEL, ELIQUIS.
Industry payments across NY — which companies pay providers there.
